Canopy Growth Corp vs JPMorgan Equity Premium Income ETF — how do they compare? Canopy Growth Corp trades at $0.96 (market cap $398.46M), while JPMorgan Equity Premium Income ETF trades at $56.62. The key difference: JPMorgan Equity Premium Income ETF is trading nearer its 52-week high, Canopy Growth Corp nearer its low. Which is the better fit depends on your goals.
| CGC | JEPI | |
|---|---|---|
Market Cap | $398.46M | — |
Sector | Health | Income / Options Overlay |
52-Week High | $1.92 | $59.88 |
52-Week Low | $0.86 | $55.29 |
Enterprise Value | $337.90M | — |
Signals from Pluang's Aura AI — not financial advice
Canopy Growth (CGC) trades at $0.96, down 1.15% on the day, with a mixed technical picture showing a bullish overall signal but bearish moving averages. The company reported a net loss of $598.12 million in 2025, with revenue declining to $269 million, though recent quarterly earnings showed one beat and two misses against expectations. Cash flow remains negative, but the balance sheet shows improving debt-to-asset ratios, down to 33.13% in 2025 from 53.61% in 2023.
The outlook is cautious; while cost-cutting and restructuring efforts are underway, profitability remains elusive, and the stock faces risks including potential delisting due to low share price. Analyst sentiment is divided, with 33% recommending buy, 41% hold, and 26% sell. Investors should weigh the potential for a turnaround against significant operational and regulatory challenges in the cannabis sector.
JEPI trades at $56.76 with no price change, showing stability amid mixed technical signals. The ETF maintains a bullish technical outlook with strong moving average support, though oscillators suggest neutral momentum. Recent dividend payments of $0.39 and $0.45 demonstrate its income-focused strategy, while financial media highlights its 8%+ yield and covered call approach as key attractions for income investors.
JEPI's covered call strategy provides consistent income but limits upside potential during bull markets. The ETF faces competition from alternatives like SPYI and tax efficiency concerns, though its active management offers drawdown protection. Current technical strength supports near-term stability, but investors should weigh income benefits against capped returns in rising markets.
Trailing returns across standard periods
Latest headlines on both assets
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.
Read more on CGC →JEPI is an actively managed ETF that seeks to deliver monthly income and stock market exposure with lower volatility. It combines an equity portfolio with an options strategy to generate steady premiums.
Read more on JEPI →